Contact us
Please fill out the details below and we will get back to you shortly.
Thank you!
We will be contacting you soon..
Close
We will be contacting you soon..
Oops! Something went wrong while submitting the form.
March 2024 - Portal Instruments is pleased to be returning to Dana Point, California to share its drug delivery technology with investors and other emerging medtech companies at LSI USA '24. Patrick Anquetil, CEO, will be presenting the updates.
LSI USA ’24, the Emerging Medtech Summit 2024 USA, takes place 18-22 March 2024 in Dana Point, CA. The event has been organised by Life Science Intelligence, Inc. (LSI) bringing together industry-leading executives from emerging companies, venture capital and private equity firms, family offices, investment banks, global strategics, and more.
June 30, 2021 - The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹
November 2024, Cambridge, MA – Seasoned drug delivery executive, Steven Kaufman, to join Portal Instruments as their Chief Commercial Officer. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
February 11, 2020 - Gerresheimer recently published an article describing Portal Instrument’s innovative primary drug container which is used in Portal’s needle-free drug delivery platform. Read the full pdf article here.
Please fill out the details below and we will get back to you shortly.